Editorial: Endocrine aspects of Noonan syndrome and related syndromes

Front Endocrinol (Lausanne). 2023 Jan 5:13:1127686. doi: 10.3389/fendo.2022.1127686. eCollection 2022.

Authors

Giorgio Radetti¹, Thomas Edouard², Laura Mazzanti³, Marco Tartaglia⁴, Martin Zenker⁵

Affiliations

¹ Marienklinik, Bolzano, Italy.
² Endocrine, Bone Diseases, and Genetics Unit Children's Hospital, Toulouse University Hospital, Toulouse, France.
³ Alma Mater Studiorum, University of Bologna, Bologna, Italy.
⁴ Genetics and Rare Diseases Research Division, Bambino Gesù Children's Hospital, Rome, Italy.
⁵ Institute of Human Genetics, University Hospital Magdeburg, Magdeburg, Germany.

No abstract available

Keywords: RAS/MAPK pathway; RASopathies; adult height; bone mineral density; growth; growth hormone; noonan syndrome (NS).

Publication types

Editorial
Comment

MeSH terms

Humans
MAP Kinase Signaling System
Noonan Syndrome* / genetics
Protein Tyrosine Phosphatase, Non-Receptor Type 11

Substances

Protein Tyrosine Phosphatase, Non-Receptor Type 11